Resuming Coverage on PetVivo (PETV).
After Being up 1,035%, Raising $11 Million, Upgrading to NASDAQ, and Retreating 87% From its High, we Resume Coverage.
Alkaline Water Co., (WTER) Announces 33rd Straight Up Quarter.
"This quarter also saw record revenue and strong continued growth. Even when compared to last year’s pantry-loading, our first quarter fiscal 2022...
Up 2,950% is Novavax (NVAX) Still a Buy?
Up 4,002% at it's peak from where we added it to the Corona Stock Review Watch List at 7.80, Thomas Niel from...
Aditxt, (ADTX) Inc. Working on Antiviral Oral Therapy for COVID-19.
Target Acquisition Has Operational and Sales Footprint in Europe, Asia, and the Middle East
LIVE QUOTE
Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.
We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...
OMNIQ (OMQS) to Begin Trading on NASDAQ
100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ.
Yes, some...
urban-gro (UGRO) We Have Another Double!
Last May we asked, "Is Urban-Gro the Most Undervalued Cannabis Play in the Market?" Looks like it was, having doubled less than...
Book: The Struggle, Ben Horowitz.
Ben Horowitz: The StruggleREADING TIME: 5 MINUTES“Life is a struggle.”— Karl Marx
In The Hard...
Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...
MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...
Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine...
Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
